OpenAlex
PricingAboutJobs
Log inGet started
Work

Galantamine Prolonged-Release Formulation in the Treatment of Mild to Moderate Alzheimer’s Disease

HTML

Year: 2005
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Dementia and Geriatric Cognitive Disorders
DOI: 10.1159/000086613
Authors: Henry Brodaty, Jody Corey-Bloom, Felix C.V. Potocnik, Luc Truyen, Michael Gold, Chandrasekhar Rao V. Damaraju
Institutions: UNSW Sydney, University of California San Diego, Janssen Research & Development (United States)
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: galantamine, sustained-release formulation, Alzheimer's disease, cholinesterase inhibitors, cognitive function, activities of daily living, neuropsychiatric symptoms, safety and tolerability, once-daily dosing
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2168956122
FWCI: 3.166
Cites: 28
Cited by: 136
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security